Trial · NCT04117945
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival (OS) | Arm A (Regorafenib) | 3.6 | 95% Confidence Interval 0.7 to NA | months | |
| Overall Survival (OS) | Arm B (Cetuximab, Panitumumab, Irinotecan) | 13.3 | 95% Confidence Interval 7.9 to NA | months | |
| First Progression-free Survival (PFS) | Arm A (Regorafenib) | 1.2 | 95% Confidence Interval 0.7 to NA | months | |
| First Progression-free Survival (PFS) | Arm B (Cetuximab, Panitumumab, Irinotecan) | 7.0 | 95% Confidence Interval 3.9 to NA | months | |
| Second PFS | Arm A (Regorafenib) | 2.3 | 95% Confidence Interval NA to NA | months | |
| Second PFS | Arm B (Cetuximab, Panitumumab, Irinotecan) | 1.8 | 95% Confidence Interval 1.8 to NA | months | |
| Sequential Treatment PFS | Arm A (Regorafenib) | 3.6 | 95% Confidence Interval 0.7 to NA | months | |
| Sequential Treatment PFS | Arm B (Cetuximab, Panitumumab, Irinotecan) | 8.9 | 95% Confidence Interval 5.9 to NA | months | |
| Objective Response Rate | Arm A (Regorafenib) | 0 | Participants | ||
| Objective Response Rate | Arm B (Cetuximab, Panitumumab, Irinotecan) | 0 | Participants | ||
| Sequential Treatment Objective Response Rate | Arm A (Regorafenib) | 0 | Participants | ||
| Sequential Treatment Objective Response Rate | Arm B (Cetuximab, Panitumumab, Irinotecan) | 0 | Participants | ||
| Number of Patients Experiencing Adverse Events | Arm A (Regorafenib) | 4 | Participants | ||
| Number of Patients Experiencing Adverse Events | Arm B (Cetuximab, Panitumumab, Irinotecan) | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04117945/results